In the same vein, precocious increase in transcriptional output could cause disease, as is the case for MYC-driven cancers and Down syndrome-associated leukaemia, and was recently found in many cancers to associate with poor prognosis3,4,7–9. This evidence concerns the gene MYC and cancer.